Outcomes and Guidelines for MRI in Patients With DCIS

Video

Melissa L. Pilewskie, MD, assistant attending physician, Memorial Sloan-Kettering Cancer Center, comments on outcomes and guidelines for MRI in patients with DCIS.

Melissa L. Pilewskie, MD, assistant attending physician, Memorial Sloan-Kettering Cancer Center, comments on outcomes and guidelines for MRI in patients with DCIS.

Clinical Pearls I

- Outcome data should support the use of any expensive test

- Data does not exist to support the routine use of MRI in DCIS patients and invasive breast cancer patients

Clinical Pearls II

- It would be beneficial to have guidelines for the appropriate use of MRI

- Currently, the use of MRI is largely dependent on the surgeon and institution

Related Videos
Video 6 - "Current Approaches to Treatment Sequencing in HER2+ Breast Cancer"
Video 5 - "Exciting Developments in HER2+ Breast Cancer"
Video 4 - "KATHERINE: Adjuvant T-DM1 vs Trastuzumab for Residual Invasive HER2+ Breast Cancer"
Video 3 - "APHINITY Trial: Pertuzumab for Patients with HER2+ Breast Cancer"
Rebecca A. Shatsky, MD, an expert on breast cancer
Related Content